The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.22BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue (TTM)
2.30BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Profit Margin
-47.97%
vs Medical Devices peers
Updated Oct 27, 2026
Beta
1.48x
vs all stocks
Updated Oct 27, 2026
52-Week Change
-35.61%
vs all stocks
Updated Oct 27, 2026
Market Capitalization
1.22BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Enterprise Value
2.58BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward P/E
5.97x
vs Medical Devices peers
Updated Oct 27, 2026
Price to Sales (TTM)
0.5313x
vs Medical Devices peers
Updated Oct 27, 2026
Price to Book (MRQ)
0.8261x
vs Medical Devices peers
Updated Oct 27, 2026
Enterprise to Revenue
1.12x
vs Medical Devices peers
Updated Oct 27, 2026
Enterprise to EBITDA
6.79x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 6.98×.Updated Oct 27, 2026
Gross Margin
61.64%
vs Medical Devices peers
Updated Oct 27, 2026
Profit Margin
-47.97%
vs Medical Devices peers
Updated Oct 27, 2026
Operating Margin
4.18%
vs Medical Devices peers
Updated Oct 27, 2026
Return on Assets (TTM)
1.20%
vs Medical Devices peers
Updated Oct 27, 2026
Return on Equity (TTM)
-54.14%
vs Medical Devices peers
Updated Oct 27, 2026
Revenue (TTM)
2.30BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue per Share (TTM)
40.07USDUpdated Oct 27, 2026
Quarterly Revenue Growth
3.20%
vs Medical Devices peers
Updated Oct 27, 2026
Gross Profit (TTM)
1.41BUSD
vs all stocks (USD)
Updated Oct 27, 2026
EBITDA (TTM)
369.35MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Net Income (TTM)
-1.10BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Quarterly Earnings Growth (YoY)
3.23%
vs Medical Devices peers
Updated Oct 27, 2026
Operating Cash Flow (TTM)
270.10MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Levered Free Cash Flow (TTM)
185.94MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Payout Ratio
0.00%
vs Medical Devices peers
Updated Oct 27, 2026
Minority Interest (Equity)
2.26MUSDFY2025 · Dec 31, 2025
Revenue
2.25BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
902.79MUSDFY2025 · Dec 31, 2025
Gross Profit
1.35BUSDFY2025 · Dec 31, 2025
Operating Income
-18.87MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-1.16BUSDFY2025 · Dec 31, 2025
Income Tax Expense
22.29MUSDFY2025 · Dec 31, 2025
Net Income
-1.18BUSDFY2025 · Dec 31, 2025
EBIT
-1.12BUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
275.14MUSDFY2025 · Dec 31, 2025
Research & Development
120.33MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
1.07BUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
34.82MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-20.75USDFY2025 · Dec 31, 2025
EPS (Diluted)
-20.75USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
57.08MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
57.08MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-1.18BUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
-820.00KUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-835.70MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-1.03BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
36.39MUSDFY2025 · Dec 31, 2025
Income Tax Paid
18.38MUSDFY2025 · Dec 31, 2025
Interest Paid
27.45MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-1.18BUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
294.38MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-2.23MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
32.92MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
7.38MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-10.75MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
-1.14MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
27.35MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-197.38MUSDFY2025 · Dec 31, 2025
Net Acquisitions
16.40MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-180.97MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
544.00MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-580.92MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-16.79MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-52.40MUSDFY2025 · Dec 31, 2025
Shares Outstanding
57.67MSharesUpdated Oct 27, 2026
Float Shares
52.76MSharesUpdated Oct 27, 2026
Shares Short
10.56MSharesUpdated Oct 27, 2026
Short Ratio
4.86days
vs all stocks
Updated Oct 27, 2026
Short % of Shares Outstanding
21.83%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 18.32%.Updated Oct 27, 2026
% Held by Insiders
1.64%
vs all stocks
Updated Oct 27, 2026
% Held by Institutions
120.33%
vs all stocks
Updated Oct 27, 2026
Total Cash (MRQ)
12.56MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Cash per Share (MRQ)
0.2180USDUpdated Oct 27, 2026
Total Debt (MRQ)
1.37BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Debt to Equity (MRQ)
0.9255x
vs Medical Devices peers
Updated Oct 27, 2026
Current Ratio (MRQ)
1.99x
vs Medical Devices peers
Updated Oct 27, 2026
Book Value per Share (MRQ)
25.61USDUpdated Oct 27, 2026
Total Assets
3.83BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.21BUSDFY2025 · Dec 31, 2025
Total Liabilities
2.34BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
2.63BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.74BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
598.47MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
36.39MUSDFY2025 · Dec 31, 2025
Accounts Receivable
442.79MUSDFY2025 · Dec 31, 2025
Inventory
584.38MUSDFY2025 · Dec 31, 2025
Accounts Payable
187.53MUSDFY2025 · Dec 31, 2025
Short-term Debt
59.74MUSDFY2025 · Dec 31, 2025
Deferred Revenue
6.50MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
51.48MUSDFY2025 · Dec 31, 2025
Long-term Debt
1.32BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
424.57MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
57.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-1.47BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.49BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
16.70USDUpdated Oct 27, 2026
52-Week High
33.13USDUpdated Oct 27, 2026
52-Week Change
-35.61%
vs all stocks
Updated Oct 27, 2026
Beta
1.48x
vs all stocks
Updated Oct 27, 2026
50-Day MA
20.34USDUpdated Oct 27, 2026
200-Day MA
23.17USDUpdated Oct 27, 2026
Avg 10-Day Volume
1.25MSharesUpdated Oct 27, 2026
Avg 30-Day Volume
1.54MSharesUpdated Oct 27, 2026
Diluted EPS (TTM)
-19.23USDUpdated Oct 27, 2026
Other Income / Expense
-1.11BUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.83×, lower than 95% of its Medical Devices peers (median 3.09×)Notable